19 MayAbout Heart Failure Heart Failure is the fastest growing cardiac disease in the U.

About Heart Failure – Heart Failure is the fastest growing cardiac disease in the U.S. According to the American Heart Association concerns, over 5 million Americans. Risks and uncertainties. More than 1 million patients in the U.S. Each year with ADHF, an acute exacerbation of heart failure. This hospitalization rate is nearly double that seen 15 years ago and is the most frequent cause of hospitalization in the U.S. For patients who are older than 65 years, with annual inpatient costs by more than $ 33 billion..

The data will be presented at an upcoming cardiology conference. The data from this study seem to suggest, in the U.S. Active doses of CD-NP suitable for evaluation in a larger double-blind, placebo-controlled study in acute heart failure patients, said James Young, Professor and Dean of Medicine at the Cleveland Clinic and member of Nile Therapeutics Scientific Advisory especially interesting board particularly interesting CD-NP is obvious effect on kidney function, which may be a unique and clinically meaningful advantage over the current standard of care. .. Secondary and exploratory analyzes showed positive effects of CD-NP on renal function, particularly at the 1.25 and 2.5 ng / kg / min dose.The drug hereby approved Leukaemia drug shows promising activity in ovarian Cells.

The drug Sprycel, intended for use by to U.S. Food and Drug Administration to patients chronic myeloid leukemia allowed, clear inhibited the growth of and invasive from ovarian cancer cell and also encouraged the deaths A study by researchers at the UCLA’s Jonsson Comprehensive Cancer Center.